Mutational Analysis of Mitochondrial DNA in Maternal Inheritance of Polycystic Ovarian Syndrome
August 2023
in “
Frontiers in Endocrinology
”
![Image of study](/images/research/0ecf9950-ca35-4e60-ba64-506df225e50f/medium/20592.jpg)
TLDR Mutations in mitochondrial DNA might significantly contribute to the development of Polycystic Ovarian Syndrome.
The research investigated the role of mitochondrial DNA (mtDNA) mutations in the development of Polycystic Ovarian Syndrome (PCOS) in three patients with a history of maternally inherited PCOS. The study identified eight mutations in six genes common among the patients, some of which resulted in translation defects that were pathogenic. Additionally, several variations in mtDNA were found, some previously associated with various types of cancer and other diseases. Two mitochondrial variants in the ATP6 gene, previously linked with hypertrophic cardiomyopathy and nonsyndromic hearing loss, were also identified. The study concluded that these mutations could play a significant role in the development of PCOS and suggested that genetic testing for these mutations could aid in diagnosis and management. However, further research is needed to establish a causal relationship, and the study recommends replicating the sequence analysis with a larger sample size in other parts of the world.